Efficacy of amikacin and ciprofloxacin against clinical isolates of Mycobacterium tuberculosis.

Background: Tuberculosis was a leading cause of death at the turn of the 20th century and continues to be one of the medical scourges of mankind. Before the availability of antimicrobial drugs the cornerstone of treatment was rest in the open air in sanatoria. The major breakthrough in treatment of tuberculosis came with the discovery of Streptomycin.

A crimean - congo haemorrhagic Fever outbreak in northern balochistan.

Objective: To describe the clinical characteristics, epidemiology, predictors of fatal outcome (PFO), and management effects of Crimean-Congo haemorrhagic fever (CCHF) patients during an outbreak in Northern Balochistan.

Design: Descriptive study.

Place And Duration Of Study: Fatima Jinnah Hospital and Combined Military Hospital, Quetta, from June to October, 2001.

Clinicopathological features of lupus anticoagulant; experience at AFIP during last seven years.

Background: The lupus anticoagulant (LA) belongs to family of immunoglobulins, most commonly an IgG isotype. These antibodies have been identified most frequently in association with thromboembolic events, recurrent fetal loss and thrombocytopenia. The aim of the present study was to evaluate the presenting clinical and pathological features in patients LA positive presenting at AFIP Rawalpindi over the period of Jan 1993 to Nov 2000.